Unidade Local de Saúde da Guarda (ULSG)
Welcome,         Profile    Billing    Logout  
 0 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Falcone, Marco
CASCADE, NCT05922124: Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii

Not yet recruiting
4
734
NA
Cefiderocol, Fetroja, Ampicillin-sulbactam, Unasyn, Colistin, Meropenem
Rambam Health Care Campus, Monaldi Hospital, Rutgers Robert Wood Johnson Medical School, Pisa University Hospital, Assaf-Harofeh Medical Center, Sheba Medical Center
Carbapenem Resistant Bacterial Infection, Acinetobacter Bacteremia, Acinetobacter Pneumonia
07/26
09/26
RESTORATiVE303, NCT06237452: VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Recruiting
3
852
Europe, Canada, US, RoW
VE303, Placebo
Vedanta Biosciences, Inc.
Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, CDI, C. Diff Infection, Recurrent Clostridium Difficile Infection, C.Difficile Diarrhea, Diarrhea Infectious
06/27
10/27
OASIS, NCT05101187: Olorofim Aspergillus Infection Study

Recruiting
3
225
Europe, Canada, Japan, US, RoW
Olorofim, Olorofim (F901318), AmBisome®, AmBisome® (liposomal amphotericin B)
F2G Biotech GmbH, Iqvia Pty Ltd, Shionogi
Invasive Aspergillosis
09/25
11/26
RETRACE, NCT04170309: Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases

Completed
N/A
428
Europe
Ceftobiprole medocaril
Advanz Pharma, AMS Advanced Medical Services GmbH, APCER Life Sciences
Renal Insufficiency, Hepatic Insufficiency, Immunosuppression
06/23
06/23
NCT06147791: Risks and Benefits of Scrotal Drainage in Penile Prosthesis Implant

Recruiting
N/A
50
Europe
External scrotal drainage
Azienda Ospedaliera Città della Salute e della Scienza di Torino
Erectile Dysfunction
10/28
10/33
Pontiggia, Silvia
RESTORATiVE303, NCT06237452: VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Recruiting
3
852
Europe, Canada, US, RoW
VE303, Placebo
Vedanta Biosciences, Inc.
Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, CDI, C. Diff Infection, Recurrent Clostridium Difficile Infection, C.Difficile Diarrhea, Diarrhea Infectious
06/27
10/27
FOSFOREAL LIFE, NCT06814899: Use of Fosfomycin in the Treatment of Bacterial Infections

Recruiting
N/A
300
Europe
Fosfomycin
Azienda Ospedaliera di Lecco
Analyze the Medical Records of Patients Admitted At ASST Lecco from 01/04/2020 to 31/12/2023 Treated with Fosfomycin IV
12/24
01/25
3-TEICO, NCT06426212: Use of Teicoplanin on a Three-weekly Administration in the Infectious Diseases Unit

Recruiting
N/A
40
Europe
Use of teicoplanin three times a week
Azienda Ospedaliera di Lecco
Comparison of Teicoplanin Used Three Times a Week in DSIs vs NDISs
05/24
06/24

Download Options